Literature DB >> 28055236

Characterization of VNTRs Within the Entire Region of SLC6A3 and Its Association with Hypertension.

Won-Tae Kim1, Se-Ra Lee1, Yun-Gil Roh1, Seung Il Kim2, Yung Hyun Choi3, Mi-Hye Mun1, Mi-So Jeong1, Sang Seok Koh1, Sun-Hee Leem1.   

Abstract

The dopamine transporter SLC6A3 (DAT1) mediates uptake of dopamine into presynaptic terminals. In addition, in previous reports, hypertensive rats were associated with DAT gene, but the genetic association with SLC6A3 and hypertension is still unknown. We examined the distribution of variable number of tandem repeats (VNTRs) and conducted polymorphic analysis of the entire region of SLC6A3. Ten VNTR regions (MS1-10) were revealed throughout the intronic and UTRs; seven VNTR regions were newly isolated and three VNTRs were previously reported. Four VNTR regions (SLC6A3-MS1, -MS4, -MS8 [rs3836790], and -MS9 [rs28363170]) showed polymorphism and these loci were found to be transmitted through meiosis following Mendelian inheritance. These VNTR polymorphisms may be useful markers for paternity mapping and DNA fingerprinting. Furthermore, we also conducted a case-control study between the controls and essential hypertensive cases. Analysis of the genotypes of SLC6A3-MS8 (rs3836790) revealed that having an 8/6-repeat allele, which was only detected in hypertensive cases, was associated with hypertension (p < 0.05). Additional significant association was identified between the short 7-repeat allele of SLC6A3-MS9 (rs28363170) and the occurrence of hypertension (odds ratio 2.02; p < 0.05). These results revealed the genetic association between SLC6A3 and hypertension, and the specific VNTR alleles of SLC6A3 may be a risk factor for hypertension.

Entities:  

Keywords:  SLC6A3; essential hypertension; minisatellite polymorphisms; solute carrier family 6

Mesh:

Substances:

Year:  2017        PMID: 28055236     DOI: 10.1089/dna.2016.3448

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  2 in total

1.  VNTR polymorphism in the breakpoint region of ABL1 and susceptibility to bladder cancer.

Authors:  Min-Hye Kim; Gi-Eun Yang; Mi-So Jeong; Jeong-Yeon Mun; Sang-Yeop Lee; Jong-Kil Nam; Yung Hyun Choi; Tae Nam Kim; Sun-Hee Leem
Journal:  BMC Med Genomics       Date:  2021-05-05       Impact factor: 3.063

2.  Evaluation of VNTR polymorphisms of dopamine transporter gene and the risk of bipolar disorder in Zahedan, southeast Iran.

Authors:  Mansour Shakiba; Mohammad Hashemi; Salah Mahdar; Zahra Rahbari; Gholamreza Bahari
Journal:  Mol Biol Res Commun       Date:  2017-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.